It is noteworthy that targeting MALAT1 globally inhibits the proliferation capacity of TSCCA-induced xenograft tumor, suggesting MALAT1 as an important prognostic factor of OSCC and a satisfactory target with therapeutic potential. Here, MALAT1 is linked to neoplasm.